5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde CAS 881674-56-2 Vonoprazan Fumarate Ma'ema'e Waena ≥99.0%

ʻO ka wehewehe pōkole:

Inoa: 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde

CAS: 881674-56-2

Maʻemaʻe: ≥99.0%

ʻAno: Melemele a me ka pauda ʻeleʻele

Ka waena o Vonoprazan Fumarate (CAS: 1260141-27-2)

High Quality, Commercialized Production

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde
Nā huaʻōlelo like Vonoprazan Fumarate (TAK-438) Waena 3
Helu CAS 881674-56-2
Helu CAT RF-PI330
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C11H8FNO
Kaumaha Molecular 189.19
Brand ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Melemele a Palaunu Pada
Lae hehee 122.0~131.0 ℃
ʻIkepili: RT(HPLC) E kulike me ka maʻamau kuhikuhi
Nalo ma ka maloo ana ≤0.50%
Koena Ma ka Ignition ≤0.50%
Na mea pili
Maemae ≥99.0%
ʻO kēlā me kēia haumia hoʻokahi ≤0.50%
Huina paumaele ≤1.0%
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Ka waena o Vonoprazan Fumarate (TAK-438) (CAS 881681-01-2)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

5-(2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde (CAS 881674-56-2) hana ma ke ʻano he reagent i ka hoʻomākaukau synthetic o nā derivatives pyrrole novel e like me ka pāpaʻi pākīpika-competitive acid blocker (P-CAB).ʻO 5-(2-Fluorophenyl)pyrrole-3-Carboxaldehyde ka waena o Vonoprazan Fumarate (CAS 1260141-27-2).ʻO Vonoprazan fumarate (Takecab®), iʻikeʻia a hoʻomohalaʻia e Takeda a me Otsuka, ua'āponoʻia e ka PMDA o Iapana i ka lāʻo Dekemaba 2014, a ua hōʻikeʻia no ka mālamaʻana i ka maʻi'ōpū, ka maʻi maʻi duodenal a me ka reflux esophagitis.Loaʻa i ka Vonoprazan fumarate kahi hana hou o ka hana i kapa ʻia ʻo potassium-competitive acid blockers, e hoʻokūkū hoʻokūkū i ka hoʻopaʻa ʻana o nā ion potassium iā H+, K+-ATPase (ʻike pū ʻia ʻo ka pauma proton) i ka hana hope loa o ka huna ʻana o ka ʻōpū o ka ʻōpū i loko o nā pūnaʻi parietal ʻōpū.ʻAʻole ʻae ʻo Vonoprazan i ka hana Na +, K + -ATPase a hiki i ka 500 mau manawa kiʻekiʻe ma mua o kā lākou mau waiwai IC50 e kūʻē i ka hana gastric H +, K + -ATPase.Eia kekahi, ʻaʻole i hoʻopilikia ʻia ka lāʻau lapaʻau e ka ʻōpū huna huna, ʻaʻole like me nā PPI.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou